Cyanobacteria derived compounds: Emerging drugs for cancer management.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of basic microbiology"
DOI: 10.1002/jobm.202100459
Abstract: The wide diversity of cyanobacterial species and their role in a variety of biological activities have been reported in the previous few years. Cyanobacteria, especially from marine sources, constitutes a major source of biologically active… read more here.
Keywords: emerging drugs; cyanobacteria derived; compounds emerging; derived compounds ... See more keywords
Newly Emerging Drugs of Abuse.
Sign Up to like & getrecommendations! Published in 2019 at "Handbook of experimental pharmacology"
DOI: 10.1007/164_2019_260
Abstract: Drug use and the associated overdose deaths have been a serious public health threat in the United States and the world. While traditional drugs of abuse such as cocaine remain popular, recreational use of newer… read more here.
Keywords: newly emerging; use; emerging drugs; chemistry ... See more keywords
Emerging Drugs of Abuse: Synthetic Cannabinoids, Phenylethylamines (2C Drugs), and Synthetic Cathinones
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Pediatric Emergency Medicine"
DOI: 10.1016/j.cpem.2017.07.009
Abstract: Abstract Emerging drugs of abuse include psychostimulants marketed as household products but containing novel psychoactive substances. These products are easily purchased and frequently change composition in response to regulatory pressure. The synthetic cannabinoids, 2C phenylethylamines,… read more here.
Keywords: synthetic cathinones; synthetic cannabinoids; emerging drugs; abuse synthetic ... See more keywords
Proactive response to tackle the threat of emerging drugs: Synthesis and toxicity evaluation of new cathinones.
Sign Up to like & getrecommendations! Published in 2018 at "Forensic science international"
DOI: 10.1016/j.forsciint.2018.07.001
Abstract: The emergence of potentially dangerous new psychoactive substances (NPS) imposes enormous challenges on forensic laboratories regarding their rapid and unambiguous identification. Access to comprehensive databases is essential for a quick characterization of these substances, allowing… read more here.
Keywords: response tackle; threat emerging; emerging drugs; new cathinones ... See more keywords
Pharmacotherapeutic options for cancer cachexia: emerging drugs and recent approvals
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2209316
Abstract: ABSTRACT Introduction Cachexia is a complex multi-factorial syndrome characterized by anorexia, inflammation, body, and skeletal muscle wasting. Early diagnosis and intervention via a multimodal approach combining nutritional counseling, exercise, and pharmacological agents is advisable. However,… read more here.
Keywords: pharmacotherapeutic options; options cancer; emerging drugs; cancer cachexia ... See more keywords
Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Emerging Drugs"
DOI: 10.1080/14728214.2017.1269743
Abstract: ABSTRACT Introduction: Cardiovascular (CV) atherosclerotic disease remains the leading cause of morbidity and mortality worldwide, despite the advances in contemporary therapies. Inflammation is an important process in atherosclerosis, leading to plaque rupture and acute coronary… read more here.
Keywords: emerging drugs; new directions; inflammation; inflammation beyond ... See more keywords
Emerging drugs for immune thrombocytopenia (ITP)
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Emerging Drugs"
DOI: 10.1080/14728214.2017.1294158
Abstract: ABSTRACT Introduction: Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by autoantibody production against platelets, increased platelet destruction, and, in some cases, impaired thrombopoiesis. The majority of affected patients have significant bleeding risks due to… read more here.
Keywords: thrombocytopenia itp; treatment; immune thrombocytopenia; emerging drugs ... See more keywords
Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Emerging Drugs"
DOI: 10.1080/14728214.2017.1330884
Abstract: ABSTRACT Introduction: Acute and chronic graft rejection continues to be an important problem after solid organ transplantation. With the introduction of potent immunosuppressive agents such as calcineurin inhibitors, the risk of rejection has been significantly… read more here.
Keywords: liver kidney; emerging drugs; rejection; kidney transplantation ... See more keywords
Emerging drugs for primary progressive multiple sclerosis
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Emerging Drugs"
DOI: 10.1080/14728214.2018.1463370
Abstract: ABSTRACT Introduction: The identification of effective therapies for progressive forms of multiple sclerosis (MS) has remains a priority and challenge for the global MS community. Despite a few proposed mechanisms, a more complete understanding of… read more here.
Keywords: ppms; emerging drugs; multiple sclerosis; primary progressive ... See more keywords
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Emerging Drugs"
DOI: 10.1080/14728214.2018.1471465
Abstract: ABSTRACT Introduction: Idiopathic pulmonary fibrosis is a chronic, progressive fibrotic lung disease of unknown etiology associated with a high morbidity and mortality. The hallmark of the disease is impaired healing after alveolar epithelial injury in… read more here.
Keywords: fibrosis; idiopathic pulmonary; emerging drugs; treatment ... See more keywords
An update: emerging drugs to treat squamous cell carcinomas of the head and neck
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Emerging Drugs"
DOI: 10.1080/14728214.2018.1543400
Abstract: ABSTRACT Introduction: Subsequent to the 2006 FDA approval of cetuximab, a variety of molecular targeting agents have been evaluated in head and neck squamous cell carcinoma (HNSCC). The treatment outcomes of recurrent and/or metastatic (R/M)… read more here.
Keywords: emerging drugs; treatment; squamous cell; hnscc ... See more keywords